Anton N. Chikaev

Siberian Branch Of The Russian Academy Of Sciences
Novosibirsk, NVS, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants.

A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants.

Journal: Frontiers in immunology
Published: June 01, 2024

Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies.

Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies.

Journal: Vaccines
Published: December 03, 2023

Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection.

Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection.

Journal: Vaccines
Published: November 02, 2023

Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation.

Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation.

Journal: Frontiers in immunology
Published: December 21, 2021

Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.

Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems.

Journal: Vaccines
Published: December 12, 2021

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern.

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern.

Journal: Cell discovery
Published: April 16, 2021

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.

Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.

Journal: Vaccines
Published: March 10, 2021

shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells.

shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells.

Journal: Vavilovskii zhurnal genetiki i selektsii
Published: March 04, 2021

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies.

Phage display as a tool for identifying HIV-1 broadly neutralizing antibodies.

Journal: Vavilovskii zhurnal genetiki i selektsii
Published: January 12, 2021

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope.

Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope.

Journal: Vaccines
Published: June 26, 2019

Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines.

Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines.

Journal: BMC medical genomics
Published: March 16, 2019

Characteristics of Artificial Immunogens Containing Peptide Mimotopes of HIV-1 Epitopes Recognized by Monoclonal Antibodies 2F5 and 2G12.

Characteristics of Artificial Immunogens Containing Peptide Mimotopes of HIV-1 Epitopes Recognized by Monoclonal Antibodies 2F5 and 2G12.

Journal: Bulletin of experimental biology and medicine
Published: September 27, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026